Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 9 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | cytochrome P450 family protein | Get druggable targets OG5_126582 | All targets in OG5_126582 |
Brugia malayi | Cytochrome P450 family protein | Get druggable targets OG5_126582 | All targets in OG5_126582 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 490 aa | 441 aa | 21.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | PAB1-binding protein , putative | 0.0054 | 0.11 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.027 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0129 | 0.4182 | 0.3704 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0086 | 0.2396 | 0.2396 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0239 | 0.8717 | 0.8717 |
Schistosoma mansoni | hypothetical protein | 0.0185 | 0.6481 | 0.8474 |
Brugia malayi | MH2 domain containing protein | 0.0239 | 0.8717 | 0.8717 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.027 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0203 | 0.7216 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0054 | 0.11 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0054 | 0.11 | 0.5 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0203 | 0.7216 | 0.7216 |
Loa Loa (eye worm) | hypothetical protein | 0.0185 | 0.6481 | 0.6481 |
Brugia malayi | hypothetical protein | 0.0054 | 0.11 | 0.11 |
Schistosoma mansoni | tar DNA-binding protein | 0.0129 | 0.4182 | 0.3704 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0054 | 0.11 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0203 | 0.7216 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0054 | 0.11 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0054 | 0.11 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0203 | 0.7216 | 0.7216 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0203 | 0.7216 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0086 | 0.2396 | 0.2396 |
Loa Loa (eye worm) | RNA binding protein | 0.0129 | 0.4182 | 0.4182 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.11 | 0.11 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0203 | 0.7216 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0203 | 0.7216 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0129 | 0.4182 | 0.3704 |
Schistosoma mansoni | tar DNA-binding protein | 0.0129 | 0.4182 | 0.3704 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0086 | 0.2396 | 0.2396 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0185 | 0.6481 | 0.6481 |
Brugia malayi | hypothetical protein | 0.0035 | 0.0312 | 0.0312 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0239 | 0.8717 | 0.8717 |
Echinococcus granulosus | tar DNA binding protein | 0.0129 | 0.4182 | 0.3704 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0054 | 0.11 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0129 | 0.4182 | 0.4182 |
Loa Loa (eye worm) | TAR-binding protein | 0.0129 | 0.4182 | 0.4182 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0203 | 0.7216 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0129 | 0.4182 | 0.4182 |
Brugia malayi | RNA binding protein | 0.0129 | 0.4182 | 0.4182 |
Echinococcus multilocularis | tar DNA binding protein | 0.0129 | 0.4182 | 0.3704 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.027 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0129 | 0.4182 | 0.3704 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0203 | 0.7216 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0054 | 0.11 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0129 | 0.4182 | 0.4182 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0086 | 0.2396 | 0.2396 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (ADMET) | = 0.6 uM | Inhibitory effect on human recombinant liver cytochrome P450 2C9 expressed in yeast strain | ChEMBL. | 11606127 |
IC50 (ADMET) | = 0.6 uM | Inhibitory effect on human recombinant liver cytochrome P450 2C9 expressed in yeast strain | ChEMBL. | 11606127 |
IC50 (ADMET) | = 100 uM | Inhibitory effect on human recombinant liver cytochrome P450 2C19 expressed in yeast strain | ChEMBL. | 11606127 |
IC50 (ADMET) | = 100 uM | Inhibitory effect on human recombinant liver cytochrome P450 2C19 expressed in yeast strain | ChEMBL. | 11606127 |
IC50 (ADMET) | = 170 uM | Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strain | ChEMBL. | 11606127 |
IC50 (ADMET) | = 170 uM | Inhibitory effect on human recombinant liver cytochrome P450 2C18 expressed in yeast strain | ChEMBL. | 11606127 |
IC50 (ADMET) | = 220 uM | Inhibitory effect on human recombinant liver Cytochrome P450 2C8 expressed in yeast strain | ChEMBL. | 11606127 |
IC50 (ADMET) | = 220 uM | Inhibitory effect on human recombinant liver Cytochrome P450 2C8 expressed in yeast strain | ChEMBL. | 11606127 |
Ki (ADMET) | = 0.1 uM | Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme | ChEMBL. | 10956186 |
Ki (ADMET) | = 0.1 uM | Binding affinity measured on human cytochrome P450 2C9 (CYP2C9) enzyme | ChEMBL. | 10956186 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.